BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22096217)

  • 21. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
    Gai X; Wei Y; Tao H; Zhu J; Li B
    Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.
    Chen SW; Yang SN; Liang JA; Shiau AC; Lin FJ
    Med Dosim; 2005; 30(4):219-27. PubMed ID: 16275564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses.
    Uzel EK; Karaçam S; Eliçin O; Uzel O
    Strahlenther Onkol; 2013 Jul; 189(7):552-8. PubMed ID: 23748231
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
    Wu Q; Chi Y; Chen PY; Krauss DJ; Yan D; Martinez A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):924-32. PubMed ID: 19801104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of anatomical and dosimetric variations in the first 15 fractions, and between fractions 16 and 25, of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Yang H; Tu Y; Wang W; Hu W; Ding W; Yu C; Zhou C
    J Appl Clin Med Phys; 2013 Nov; 14(6):3918. PubMed ID: 24257268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
    Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
    Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
    Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the assignment method of intensity modulated radiotherapy plan for nasopharyngeal carcinoma based on MR images].
    Yao XS; Gong GZ; Ren JX; Zuo GP; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):850-855. PubMed ID: 34407590
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of deformed image-based dose calculations for adaptive radiotherapy of nasopharyngeal carcinoma.
    Poon M; Holborn C; Cheng KF; Fung WWK; Chiu G
    Med Dosim; 2017 Winter; 42(4):273-281. PubMed ID: 28781156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose planning study of target volume coverage with intensity- modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience.
    Phua Chee Ee V; Tan BS; Tan AL; Eng KY; Ng BS; Ung NM
    Asian Pac J Cancer Prev; 2013; 14(4):2243-8. PubMed ID: 23725120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: improvement of the therapeutic ratio with helical tomotherapy vs segmental multileaf collimator-based techniques.
    Chen AM; Yang CC; Marsano J; Liu T; Purdy JA
    Br J Radiol; 2012 Aug; 85(1016):e537-43. PubMed ID: 22253350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric evaluation of automatic and manual plans for early nasopharyngeal carcinoma to radiotherapy.
    Zhang Q; Peng Y; Song X; Yu H; Wang L; Zhang S
    Med Dosim; 2020 Spring; 45(1):e13-e20. PubMed ID: 31466735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of the transverse diameter and volume and dosimetry before the 25th fraction during the course of intensity-modulated radiation therapy (IMRT) for patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Ding W; Shan G; Wang W; Yu C; Wang B; Shao M; Wang J; Yang W
    Med Dosim; 2012; 37(2):225-9. PubMed ID: 22189032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
    Cheng JC; Chao KS; Low D
    Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.
    Wang X; Lu J; Xiong X; Zhu G; Ying H; He S; Hu W; Hu C
    Med Dosim; 2010; 35(2):151-7. PubMed ID: 19931037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.
    Niu X; Chang X; Gao Y; Hu C; Kong L
    Radiat Oncol; 2013 Oct; 8():226. PubMed ID: 24083351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
    Sun Y; Yu XL; Luo W; Lee AW; Wee JT; Lee N; Zhou GQ; Tang LL; Tao CJ; Guo R; Mao YP; Zhang R; Guo Y; Ma J
    Radiother Oncol; 2014 Mar; 110(3):390-7. PubMed ID: 24721546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
    Mao YP; Yin WJ; Guo R; Zhang GS; Fang JL; Chi F; Qi ZY; Liu MZ; Ma J; Sun Y
    Chin J Cancer; 2015 May; 34(5):189-97. PubMed ID: 26058563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.